Brynley Hull,Alexandra Hendry,Kristine Macartney et al.
Brynley Hull et al.
Overview: We analysed Australian Immunisation Register (AIR) data, predominantly for National Immunisation Program (NIP) funded vaccines, as at 4 February 2024 for children, adolescents and adults, focusing on the calenda...
Alison Jaworski,Carleigh Cowling,Gordana Popovic et al.
Alison Jaworski et al.
Trachoma is the world's leading infectious cause of preventable blindness and is linked to poor living conditions. Australia has remained the only high-income country where trachoma is endemic, primarily in remote Indigenous communities in ...
Transport time, not transport method, predicts Neisseria gonorrhoeae culture yield in an urban setting [0.03%]
运输时间，而不是运输方法，可以预测城市环境中淋病奈瑟菌的培养产量
Arthur Wong,Tanya Applegate,Alison Mahony et al.
Arthur Wong et al.
Antimicrobial resistance (AMR) in Neisseria gonorrhoeae poses a pressing public health threat. Current surveillance programs via antimicrobial susceptibility testing (AST) depend on successfully cultivating the organism via bacterial cultur...
SAEFVIC: Surveillance of adverse events following immunisation (AEFI) in Victoria, Australia, 2019-2020 [0.03%]
2019—2020年澳大利亚维多利亚州疫苗接种后不良事件(AEFI)监测报告(SAEFVIC)
Jesse Fryk,Hazel Clothier,Daneeta Hennessy et al.
Jesse Fryk et al.
Background: Adverse event following immunisation (AEFI) surveillance in Victoria is conducted through Surveillance of Adverse Events Following Vaccination in the Community (SAEFVIC), an enhanced surveillance system integr...
Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2024 [0.03%]
2024年墨尔本世卫组织流感参考和研究合作中心接收和检测的流感病毒报告
Jessica Miller,Tanya Diefenbach-Elstob,Rachel Wordsworth et al.
Jessica Miller et al.
As part of its role in the World Health Organization (WHO) Global Influenza Surveillance and Response System (GISRS), the WHO Collaborating Centre for Reference and Research on Influenza in Melbourne received 12,180 human influenza-positive...
Maternal vaginal colonisation with Neisseria meningitidis serogroup B and late onset neonatal invasive meningococcal disease [0.03%]
脑膜炎奈瑟菌B群阴道定植与新生儿晚发型侵袭性脑膜炎球菌病关系研究
Nadiya Brell,Chloe Story,Sebastiaan Van Hal et al.
Nadiya Brell et al.
Here we report a case of late onset neonatal invasive meningococcal disease that was vertically transmitted, with maternal vaginal swab at the time of delivery and neonatal cerebrospinal fluid culture positive for Neisseria meningitidis. Wh...
Investigation and response to an outbreak of mpox cases linked to a high-risk group event in Southeast Queensland in May 2024 [0.03%]
调查并回应2024年5月发生在澳大利亚东南部昆士兰高风险群体活动中与猴痘相关的暴发事件
Maggie Miller,Deena Malloy,Megan Young et al.
Maggie Miller et al.
Objective: The primary aim of this paper is to describe the outbreak investigation and public health response to a cluster of mpox cases that occurred in Southeast Queensland; and to investigate transmission dynamics to i...
Australian Gonococcal Surveillance Program, 1 April to 30 June 2025 [0.03%]
2025年4月1日至6月30日澳大利亚淋病 surveillance 程序报告
Monica Lahra,Siobhan Hurley,Sebastiaan Van Hal et al.
Monica Lahra et al.
The National Neisseria Network (NNN), Australia, established in 1979, comprises reference laboratories in each state and territory. Since 1981, the NNN has reported data for the Australian Gonococcal Surveillance Programme (AGSP), on antimi...
Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2025 [0.03%]
澳大利亚脑膜炎监测报告：2025年4月1日至6月30日报告期内
Monica Lahra,Tiffany Hogan
Monica Lahra
The reference laboratories of the Australian Meningococcal Surveillance Programme (AMSP) report data on the number of cases of invasive meningococcal disease (IMD) confirmed by laboratory testing using culture and molecular based techniques...
Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2024 [0.03%]
2024年澳大利亚儿科监测单位（APSU）年度监测报告
Suzy Teutsch,Carlos Nunez,Anne Morris et al.
Suzy Teutsch et al.
Since 1993, the Australian Paediatric Surveillance Unit (APSU) has been conducting prospective national surveillance of rare conditions in Australian children, including communicable diseases and complications of communicable diseases. In 2...